bioRxiv , (2022)
Canadian drug manufacturers and distributors say they are not negotiating with Florida on its plan to import cheaper prescription drugs from Canada, contradicting claims from Florida that they are working diligently to negotiate with Canadian manufacturers. Innovative Medicines Canada has not spoken to Florida about this, and to our knowledge, neither have our members." The program, approved by the FDA in 2024, has yet to ship a single drug, despite costing the state $80 million
10.1371/journal.pone.0103114 [DOI] [PMC free article] [PubMed] [Google Scholar] Darsalia V., Olverling A., Larsson M., Mansouri S., Nathanson D., Nystrom T., et al
A case of severe m
Trial SURPASS-2 (NEJM 2021) Population 1,879 adults with T2D vs semaglutide 1 mg
Advances in lasso peptide discovery, biosynthesis, and function